DOI:

10.37988/1811-153X_2022_2_45

Cytokine status of the oral fluid in periodontitis in patients with a survey of coronavirus infection

Authors

  • 1 Lugansk State Medical University, 91045, Lugansk, Lugansk People’s Republic

Abstract

On the development of the development of dentistry, periodontal diseases are an identified problem and occupy a leading position in the special dental diseases of countries in different countries. COVID-19 and periodontitis measure the proportion of the cytokine status of the oral fluid, therefore, the question of the calorie content of studying the level of salivary cytokines in people with periodontal diseases who have had a coronavirus infection is relevant, since in the case of studying the COVID-19 process, data were found that allow for accurate interpretation in relation to periodontitis. The aim of the study is to determine the immunological parameters of the oral fluid of patients with periodontitis who are not affected by coronavirus infection.
Materials and methods.
The study involved 100 people: 40 healthy participants, 30 patients with chronic periodontitis, 40 patients with periodontitis who had COVID-19. The fact of a coronavirus infection was established on the basis of anamnesis data and an enzyme immunoassay for IgG antibodies to the SARS-CoV-2 S protein. The level of cytokines (IL-2, IL-4, IL-6, IL-8) is determined by enzyme-linked immunosorbent assay.
Results.
Apparently healthy participants have lower levels of all cytokines. Patients with periodontitis who have recovered from COVID-19 require higher levels of IL-6 and IL-8 (by 2 pg/ml and 23 249 pg/ml, respectively) compared to patients with periodontitis who have not had a coronavirus infection. However, the difference in the concentration of IL-2 and IL-4 (by 0.3 pg/ml and 2.6 pg/ml, respectively) was not statistically significant. No difference was found at the level of IL-2 and IL-4.
Conclusion.
To assess the cytokine status of the oral fluid in patients with periodontitis, the determination of IL-2 and IL-4 is most often used due to the fact that their level is relatively high in the presence of a coronavirus infection.

Key words:

cytokine status, oral fluid, periodontitis, COVID-19

For Citation

[1]
Rybovalov M.V., Pavlenko T.A. Cytokine status of the oral fluid in periodontitis in patients with a survey of coronavirus infection. Clinical Dentistry (Russia).  2022; 25 (2): 45—49. DOI: 10.37988/1811-153X_2022_2_45

References

  1. Taylor J.J. Protein biomarkers of periodontitis in saliva. ISRN Inflamm. 2014; 2014: 593151. PMID: 24944840
  2. de Campos B.O., Fischer R.G., Gustafsson A., Figueredo C.M. Effectiveness of non-surgical treatment to reduce il-18 levels in the gingival crevicular fluid of patients with periodontal disease. Braz Dent J. 2012; 23 (4): 428—32. PMID: 23207861
  3. AlMoharib H.S., AlMubarak A., AlRowis R., Geevarghese A., Preethanath R.S., Anil S. Oral fluid based biomarkers in periodontal disease: part 1. Saliva. J Int Oral Health. 2014; 6 (4): 95—103. PMID: 25214743
  4. Graves D. Cytokines that promote periodontal tissue destruction. J Periodontol. 2008; 79 (8 Suppl): 1585—91. PMID: 18673014
  5. Heidari Z., Moudi B., Mahmoudzadeh-Sagheb H. Immunomodulatory factors gene polymorphisms in chronic periodontitis: an overview. BMC Oral Health. 2019; 19 (1): 29. PMID: 30755190
  6. Buduneli N., Kinane D.F. Host-derived diagnostic markers related to soft tissue destruction and bone degradation in periodontitis. J Clin Periodontol. 2011; 38 Suppl 11: 85—105. PMID: 21323706
  7. Hasan A., Palmer R.M. A clinical guide to periodontology: pathology of periodontal disease. Br Dent J. 2014; 216 (8): 457—61. PMID: 24762896
  8. Andrukhov O., Ulm C., Reischl H., Nguyen P.Q., Matejka M., Rausch-Fan X. Serum cytokine levels in periodontitis patients in relation to the bacterial load. J Periodontol. 2011; 82 (6): 885—92. PMID: 21138356
  9. Tisoncik J.R., Korth M.J., Simmons C.P., Farrar J., Martin T.R., Katze M.G. Into the eye of the cytokine storm. Microbiol Mol Biol Rev. 2012; 76 (1): 16—32. PMID: 22390970
  10. Ertugrul A.S., Sahin H., Dikilitas A., Alpaslan N., Bozoglan A. Comparison of CCL28, interleukin-8, interleukin-1β and tumor necrosis factor-alpha in subjects with gingivitis, chronic periodontitis and generalized aggressive periodontitis. J Periodontal Res. 2013; 48 (1): 44—51. PMID: 22812409
  11. Bonecchi R., Galliera E., Borroni E.M., Corsi M.M., Locati M., Mantovani A. Chemokines and chemokine receptors: an overview. Front Biosci (Landmark Ed). 2009; 14 (2): 540—51. PMID: 19273084
  12. Armitage G.C., Cullinan M.P. Comparison of the clinical features of chronic and aggressive periodontitis. Periodontol 2000. 2010; 53: 12—27. PMID: 20403102
  13. Preshaw P.M., Taylor J.J. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? J Clin Periodontol. 2011; 38 Suppl 11: 60—84. PMID: 21323705
  14. Dinarello C.A. Historical insights into cytokines. Eur J Immunol. 2007; 37 Suppl 1: S34—45. PMID: 17972343
  15. Balashova N., Dhingra A., Boesze-Battaglia K., Lally E.T. Aggregatibacter actinomycetemcomitans leukotoxin induces cytosol acidification in LFA-1 expressing immune cells. Mol Oral Microbiol. 2016; 31 (1): 106—14. PMID: 26361372
  16. Sorsa T., Mäntylä P., Tervahartiala T., Pussinen P.J., Gamonal J., Hernandez M. MMP activation in diagnostics of periodontitis and systemic inflammation. J Clin Periodontol. 2011; 38 (9): 817—9. PMID: 21707693
  17. Kachlany S.C. Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy. J Dent Res. 2010; 89 (6): 561—70. PMID: 20200418
  18. Wu Y., Shu R., Luo L.J., Ge L.H., Xie Y.F. Initial comparison of proteomic profiles of whole unstimulated saliva obtained from generalized aggressive periodontitis patients and healthy control subjects. J Periodontal Res. 2009; 44 (5): 636—44. PMID: 19453860
  19. Baum B.J., Yates J.R. 3rd, Srivastava S., Wong D.T., Melvin J.E. Scientific frontiers: emerging technologies for salivary diagnostics. Adv Dent Res. 2011; 23 (4): 360—8. PMID: 21917746
  20. Kapoor U., Sharma G., Juneja M., Nagpal A. Halitosis: Current concepts on etiology, diagnosis and management. Eur J Dent. 2016; 10 (2): 292—300. PMID: 27095913
  21. Song B., Zhang Y.L., Chen L.J., Zhou T., Huang W.K., Zhou X., Shao L.Q. The role of Toll-like receptors in periodontitis. Oral Dis. 2017; 23 (2): 168—180. PMID: 26923115
  22. Lertpimonchai A., Rattanasiri S., Arj-Ong Vallibhakara S., Attia J., Thakkinstian A. The association between oral hygiene and periodontitis: a systematic review and meta-analysis. Int Dent J. 2017; 67 (6): 332—343. PMID: 28646499
  23. Qin C., Zhou L., Hu Z., Zhang S., Yang S., Tao Y., Xie C., Ma K., Shang K., Wang W., Tian D.S. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020; 71 (15): 762—768. PMID: 32161940
  24. P. Bhargava, P. Panda, V. Ostwal, A. Ramaswamy Repurposing valproate to prevent acute respiratory distress syndrome/acute lung injury in COVID-19: A review of immunomodulatory action. Cancer Research, Statistics, and Treatment. 2020; 3 (5): 65—70. DOI: 10.4103/crst.crst_156_20
  25. Peng X., Wang Y., Xi X., Jia Y., Tian J., Yu B., Tian J. Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm. Cardiovasc Drugs Ther. 2021; 35 (2): 231—247. PMID: 33404925
  26. Han H., Ma Q., Li C., Liu R., Zhao L., Wang W., Zhang P., Liu X., Gao G., Liu F., Jiang Y., Cheng X., Zhu C., Xia Y. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020; 9 (1): 1123—1130. PMID: 32475230
  27. McGonagle D., Sharif K., O.’Regan A., Bridgewood C. The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmun Rev. 2020; 19 (6): 102537. PMID: 32251717
  28. Mulchandani R., Lyngdoh T., Kakkar A.K. Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis. Eur J Clin Invest. 2021; 51 (1): e13429. PMID: 33058143
  29. Rabaan A.A., Al-Ahmed S.H., Muhammad J., Khan A., Sule A.A., Tirupathi R., Mutair A.A., Alhumaid S., Al-Omari A., Dhawan M., Tiwari R., Sharun K., Mohapatra R.K., Mitra S., Bilal M., Alyami S.A., Emran T.B., Moni M.A., Dhama K. Role of Inflammatory cytokines in COVID-19 patients: A review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to counter cytokine storm. Vaccines (Basel). 2021; 9 (5): 436. PMID: 33946736
  30. Li L., Li J., Gao M., Fan H., Wang Y., Xu X., Chen C., Liu J., Kim J., Aliyari R., Zhang J., Jin Y., Li X., Ma F., Shi M., Cheng G., Yang H. Interleukin-8 as a biomarker for disease prognosis of coronavirus disease-2019 patients. Front Immunol. 2020; 11: 602395. PMID: 33488599

Received

April 3, 2022

Accepted

May 5, 2022

Published on

June 1, 2022